Comparison of prioritisation algorithms for the selection of patients for medication reviews in the emergency department: a cross-sectional study

Author:

Korup Signe Gejr,Almarsdóttir Anna BirnaORCID,Magnussen Line

Abstract

Abstract Background Risk prioritisation algorithms provide patients with a risk category that guides pharmacists to choose those needing medication reviews (MRs) the most. For this study the Medicine Risk Score (MERIS) and a modified Assessment of Risk Tool (ART) were used. Aim To examine how the selection of patients by the clinical pharmacists in an emergency department for MRs compared with the categorisation provided by MERIS and a modified version of ART (mART). Furthermore, examine the agreement between MERIS and mART. Method A cross-sectional study was conducted using data on all admitted patients during a two-month period. Data were entered into the prioritisation algorithms and independently ranked by the six pharmacists who were observed as they selected patients for MR. Risk scores and categorisations were compared between the algorithms and the pharmacists’ ranking using t-test, Z-test, Chi square, Kruskal Wallis H-test, or Kappa statistics. Results The study included 1133 patients. Significant differences were found between the pharmacists and the algorithms. The sensitivity and specificity of MERIS were 37.8% and 73.6%, for mART, 33.0% and 75.9%. Kappa was 0.58, showing moderate agreement. No significant differences were observed between the individual pharmacists’ selection, but differences were significant between how pharmacists ranked the importance of the provided MRs. Conclusion Pharmacists disagreed with the risk categorisation provided by MERIS and mART. However, MERIS and mART had similar sensitivity, specificity, and moderate agreement. Further research should focus on how clinical algorithms affect the selection of patients and on the importance of the MRs carried out by pharmacists.

Funder

Royal Library, Copenhagen University Library

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3